Interpretation ID: Spelcast5635

Mr. Derek Fletcher
Snug Seat
12801 E. Independence Blvd.
PO Box 1739
Matthews, NC 28106

Dear Mr. Fletcher:

This responds to your e-mail letter and phone conversation with Ms. Deirdre Fujita of my staff, in which you requested a temporary exemption from the child restraint anchorage system requirements of Federal Motor Vehicle Safety Standard (FMVSS) No. 213, Child restraint systems. The agency does not have authority to grant exemptions to equipment manufacturers. However, in this limited instance, we will exercise our discretion not to institute enforcement proceedings with respect to the Spelcast special needs child restraint system (CRS).

In your letter, you explained that the Spelcast is specifically designed to safely transport children in hip spica casts or with other lower extremity casting. You stated that typically, a child only uses the Spelcast for a period of 6 to 8 weeks while in a cast. According to your letter, hospitals temporarily loan the Spelcast to individuals with children in casts. You describe the loans as being administered by trained hospital staff, who provide instruction on the restraints installation and use.

Under FMVSS No. 213, all CRSs (except harnesses, car beds, and belt-positioning seats) manufactured on or after September 1, 2002, must be equipped with a means of attaching to a vehicles child restraint anchorage system [1] . This requirement, along with vehicle anchorage requirements, improves the compatibility of vehicle seats and CRSs and provides a universal system for installing CRSs. Increasing the ease of installation reduces the instances of incorrectly installed restraints. Improved compatibility and proper installation increase the effectiveness of a CRS in preventing death or injury.

You indicated that the Spelcast is currently not offered for sale because it does not meet the LATCH requirements of FMVSS No. 213. However, you stated that when the Spelcast was sold, it was primarily sold to hospitals and child passenger safety agencies and was not available through any retail outlet. You stated that there are currently no other CRSs available that accommodate the needs of children in casts and that the only alternative is ambulance transport.

As a CRS, the Spelcast must meet all applicable provisions of FMVSS No. 213, including those for the child restraint anchorage system attachments. When a Federal motor vehicle safety standard contains a requirement applicable to a product, Federal law prohibits any person from manufacturing, selling, or importing a new product that does not comply with that requirement. See, 49 U.S.C. 30112. The Federal law governing our agency does not explicitly provide for exempting manufacturers of equipment items, such as CRSs, from the application of the standards.

However, we believe that flexibility is called for to accommodate the special medical needs of the individuals who rely on your product. The Spelcast provides a transportation option for a small population that has very limited alternatives. One of the objectives of the LATCH requirements is to minimize improper installation of CRSs. Because of the distribution methods for the Spelcast, users receive personal instruction from qualified staff. This instruction, combined with the limited and controlled distribution of the child restraint, reduces the chance that a Spelcast will be improperly installed. However, to continue to ensure that only properly instructed individuals would use these seats and to prevent the seats general use, a system is needed to ensure that a loaned seat is returned to the hospital or agency once a child can be accommodated by a CRS certified to all the requirements of FMVSS No. 213.

In your phone conversation, you explained that the seat is being redesigned in cooperation with another CRS manufacturer to comply with the LATCH requirements, but that the availability of the new seat is still about 8 months away. Based on this and other information mentioned in this letter, we will exercise our discretion not to enforce the child restraint anchorage system requirements of FMVSS No. 213 against the Spelcast for a period of 8 months from the date of this letter. This will provide an alternative to ambulance transport until the redesigned seat is available. Note that this determination applies only to the child restraint anchorage provisions of FMVSS No. 213 and that the Spelcast must still comply with all other relevant portions of the standard.

I hope that this letter resolves your problem. If you have any further questions, please contact Mr. Chris Calamita of my staff at (202) 366-2992.

Sincerely,

Jacqueline Glassman
Chief Counsel

ref:213
d.10/1/03